CuteraCUTR
About: Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.
Employees: 430
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
20.99% less ownership
Funds ownership: 54.23% [Q2] → 33.24% (-20.99%) [Q3]
30% less funds holding
Funds holding: 80 [Q2] → 56 (-24) [Q3]
49% less call options, than puts
Call options by funds: $192K | Put options by funds: $379K
68% less capital invested
Capital invested by funds: $16.5M [Q2] → $5.27M (-$11.2M) [Q3]
78% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 27
80% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 30
Research analyst outlook
We haven’t received any recent analyst ratings for CUTR.